Search for: "MERRELL"
Results 421 - 440
of 602
Sort by Relevance
|
Sort by Date
7 Apr 2011, 1:16 pm
Richardson–Merrell, Inc., 628 F. [read post]
1 Apr 2011, 3:00 am
Merrell Dow Pharmaceuticals, Inc., 52 Baylor L. [read post]
18 Mar 2011, 1:28 pm
Merrell Dow Pharmaceuticals, Inc. laid down the standard for admissibility of expert testimony. [read post]
18 Mar 2011, 10:04 am
Oct. 24, 1996) Merrell Dow Pharms., Inc. v. [read post]
18 Mar 2011, 9:58 am
Id. at 374 (relying upon and quoting from Merrell Dow Pharms., Inc. v. [read post]
18 Mar 2011, 9:58 am
” Id. at 374 (relying upon and quoting from Merrell Dow Pharms., Inc. v. [read post]
16 Mar 2011, 9:15 am
Merrell Dow Pharm., 229 N.J. [read post]
11 Mar 2011, 2:03 pm
Merrell Dow Pharmaceuticals, Inc., the United States Supreme Court ruled that federal judges may no longer use the proxy of general acceptance by specialists as the test for determining the admissibility of scientific testimony. [read post]
24 Feb 2011, 1:49 pm
Richardson-Merrell, Inc., 643 F. [read post]
22 Feb 2011, 7:27 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), in analyzing the expert presentations relating to the Rule 23 requirements, Plaintiffs contend that the Ninth Circuit found this to be no abuse of discretion, and that it did not matter because the district court judge was "guided by Daubert," concluded that the expert opinions were "based on valid principles," and were "sufficiently probative" of the Rule 23 requirements. [read post]
22 Feb 2011, 7:27 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), in analyzing the expert presentations relating to the Rule 23 requirements, Plaintiffs contend that the Ninth Circuit found this to be no abuse of discretion, and that it did not matter because the district court judge was "guided by Daubert," concluded that the expert opinions were "based on valid principles," and were "sufficiently probative" of the Rule 23 requirements. [read post]
8 Feb 2011, 11:47 am
Merrell Dow Pharms., Inc., 509 U.S. 579, 588-91 (1993). [read post]
30 Jan 2011, 5:29 pm
Merrell Dow Pharms., Inc., 43 F.3d 1311, 1315 (9th Cir.1995) (“ Daubert II ”). [read post]
27 Jan 2011, 5:14 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 589 (1993), and the Federal Rules of Evidence, however, the court explained that the rule fails to tie a reasonable royalty base to the facts of the individual case and, accordingly, affirmed the grant of a new trial on damages. [read post]
25 Jan 2011, 10:06 am
Merrell Dow Pharmaceuticals, 509 U.S. 579 (1993). [read post]
11 Jan 2011, 6:08 pm
In this case, the Federal Court did not abuse its discretion when it excluded evidence of the results of the HGN FST. [read post]
7 Jan 2011, 3:03 pm
Merrell Dow Pharmaceutics. [read post]
4 Jan 2011, 4:08 pm
Merrell Dow Pharm., Inc., 509 U.S. 589 (1993)). [read post]
4 Jan 2011, 8:52 am
Merrell Dow Pharm., Inc., 509 U.S. 589 (1993)). [read post]
3 Jan 2011, 5:21 pm
McKeown Leo Mazur Trent Merrell James Mintz Andre Nel Henry Notthaft Mark Nowotarski Sue D. [read post]
